Author:
Méndez-Lara Karen Alejandra,Santos David,Farré Núria,Nan Madalina Nicoleta,Pallarès Víctor,Pérez-Pérez Antonio,Alonso Núria,Escolà-Gil Joan Carles,Blanco-Vaca Francisco,Julve Josep
Funder
Fundación Española de Arteriosclerosis para Nutrición “Manuel de Oya” 2015
Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III
FEDER “Una manera de hacer Europa”
La Marató de TV3 2016
AGAUR
Reference40 articles.
1. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia;Marks;Atherosclerosis,2003
2. Cardioprotective functions of HDLs;Rye;J Lipid Res,2014
3. Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia;Bellanger;Arterioscler Thromb Vasc Biol,2011
4. Residual cardiovascular risk despite optimal LDL cholesterol reduction with statins: the evidence, etiology, and therapeutic challenges;Sampson;Curr Atheroscler Rep,2012
5. Niacin or ezetimibe for patients with, or at risk of coronary heart disease;Guthrie;Clin Med Insights Cardiol,2010